Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


StemPath Inc.

Latest From StemPath Inc.

Stem Cells: What's the Business Model?

The science of stem cells is progressing, slowly but surely, towards the ultimate goal of creating a therapeutic. The challenge is now largely economic: convincing investors that stem cells present a viable business opportunity.

BioPharmaceutical Strategy

StemPath Inc.

StemPath makes use of stem cells already present in tissues like the heart, for heart muscle regeneration.

BioPharmaceutical Regenerative Medicine

Stem Cells: Heath Care's Panacea or Pariah?

The field of stem cells is still plagued by issues of ethics, efficacy, and economics.

BioPharmaceutical Regenerative Medicine

Start-Up Previews (07/05)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile groups: Orthopedic Soft Tissue Repair, Stem Cells: Heath Care's Panacea or Pariah, and Nowhere to Hide: RFID Comes to Health Care. Plus these Start-Ups across Health Care: AC Immune, Alimera Sciences, Mitralign and Small Bone Innovations.

See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals